Insider Transactions in Q1 2025 at Neuroone Medical Technologies Corp (NMTC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,376
-4.3%
|
$7,376
$1.16 P/Share
|
|
Feb 18
2025
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,812
-0.62%
|
$1,812
$1.16 P/Share
|
|
Feb 18
2025
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
71,325
-6.28%
|
$71,325
$1.16 P/Share
|
|
Feb 14
2025
|
Paul Buckman Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,778
+16.88%
|
-
|
|
Feb 14
2025
|
Edward Andrle Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,778
+23.19%
|
-
|
|
Feb 14
2025
|
Jeffrey S Mathiesen Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,778
+19.54%
|
-
|
|
Jan 31
2025
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.15%
|
$252
$1.15 P/Share
|
|
Jan 31
2025
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$90
$1.15 P/Share
|
|
Jan 31
2025
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.2%
|
$2,239
$1.15 P/Share
|